Macrogenics Stock Short Ratio
| MGNX Stock | USD 1.71 0.01 0.59% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess MacroGenics' long-term financial health and intrinsic value.
MacroGenics | Build AI portfolio with MacroGenics Stock |
MacroGenics Company Short Ratio Analysis
MacroGenics' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current MacroGenics Short Ratio | 3.89 X |
Most of MacroGenics' fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MacroGenics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, MacroGenics has a Short Ratio of 3.89 times. This indicator is about the same for the Biotechnology average (which is currently at 3.9) sector and 47.5% lower than that of the Health Care industry. The short ratio for all United States stocks is 2.75% higher than that of the company.
MacroGenics Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MacroGenics' direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MacroGenics could also be used in its relative valuation, which is a method of valuing MacroGenics by comparing valuation metrics of similar companies.MacroGenics is currently under evaluation in short ratio category among its peers.
MacroGenics Fundamentals
| Return On Equity | -0.7 | ||||
| Return On Asset | -0.22 | ||||
| Profit Margin | (0.22) % | ||||
| Operating Margin | (1.65) % | ||||
| Current Valuation | (29.89 M) | ||||
| Shares Outstanding | 63.21 M | ||||
| Shares Owned By Insiders | 3.25 % | ||||
| Shares Owned By Institutions | 76.59 % | ||||
| Number Of Shares Shorted | 3.73 M | ||||
| Price To Earning | (4.54) X | ||||
| Price To Book | 2.35 X | ||||
| Price To Sales | 0.67 X | ||||
| Revenue | 148.34 M | ||||
| Gross Profit | (16.09 M) | ||||
| EBITDA | (57.37 M) | ||||
| Net Income | (66.97 M) | ||||
| Cash And Equivalents | 133.74 M | ||||
| Cash Per Share | 2.18 X | ||||
| Total Debt | 37.46 M | ||||
| Debt To Equity | 0.16 % | ||||
| Current Ratio | 3.30 X | ||||
| Book Value Per Share | 0.74 X | ||||
| Cash Flow From Operations | (68.37 M) | ||||
| Short Ratio | 3.89 X | ||||
| Earnings Per Share | (0.56) X | ||||
| Price To Earnings To Growth | 0.01 X | ||||
| Target Price | 3.75 | ||||
| Number Of Employees | 341 | ||||
| Beta | 1.64 | ||||
| Market Capitalization | 110.32 M | ||||
| Total Asset | 261.65 M | ||||
| Retained Earnings | (1.17 B) | ||||
| Working Capital | 161.96 M | ||||
| Current Asset | 342.38 M | ||||
| Current Liabilities | 23.29 M | ||||
| Net Asset | 261.65 M |
About MacroGenics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MacroGenics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MacroGenics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MacroGenics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for MacroGenics Stock Analysis
When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.